February 9, 2022 (Investorideas.com Newswire) In a phase 2 clinical study, Todos Medical’s oral antiviral Tollovir showed a 100% reduction in mortality from COVID-19.
Todos COVID-19 Drug Shows Superiority to Remdesivir,Takes Dying Off the Table
You may also like
Latest News
Fed Bank President: Banking Crisis Tips US Economy Toward Recession
The president of the Federal Reserve Bank of Minneapolis, Neel Kashkari, says the ...
Latest News
Former Treasury Official Warns of Complete Economic Implosion if US Dollar Loses Global Reserve Currency Status
Former Assistant Secretary for Public Affairs for the U.S. Department of the Treasury ...
Latest News
Market Extra: Office property woes could be tip of iceberg if credit freezes up as $1 trillion bill comes due
Creditors eager to avoid steep losses on half-empty office buildings in the wake ...
Latest News
Law Firm’s White Paper Claims US Bank Regulators Are Waging a ‘Clandestine Financial War’ Against Crypto Businesses
According to a recent white paper published by four members of the law ...
Latest News
The Tell: International stocks outperform, decouple from U.S. equities by ‘unusual degree’
International stocks are broadly outperforming this quarter, decoupling from the U.S. to an ...
Latest News
: Uber CEO’s pay rose to $24 million last year
Uber Technologies Inc. Chief Executive Dara Khosrowshahi’s total compensation last year rose 22% ...
